ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

LMO1 Promotes the Development of Hepatocellular Carcinoma by Regulation of bcl-2 and bax

Zhang, Jianfeng; Peng, Bojian; Li, Zhuowen; Zhang, Yuan; Zhang, Yongjun; Lu, Xiushan; Cao, Yanwen; Dai, Zijun; Xiong, Chuanyin*南方医科大学
Journal of Biomaterials and Tissue Engineering2023-3DOI: 10.1166/jbt.2023.3277
9阅读
引用收藏
分享

摘要

The existing treatments have no satisfactory outcomes for hepatocellular carcinoma (HCC). LMO1 is abnormally expressed in several tumors, but its relationship with HCC is unclear. Therefore, we intend to evaluate LMO1's role in HCC and the clinical significance. The HCC patients cancer tissues and adjacent tissues were collected. LMO1/control-siRNA was transfected into HepG2 cells followed by analysis of relevant protein expression by immunohistochemistry and Western blot, LMO1 mRNA level by qPCR, cell proliferation by CCK8 assay and apoptosis by flow cytometry. LMO1 positive rate was significantly elevated in HCC tissues relative to adjacent tissues. LMO1 expression was related to TNM stage and lymph node metastasis of tumor tissues (P < 0.05). Patients with positive LMO1 level had a lower cumulative survival rate than those with negative expression (P < 0.05). TNM stage, lymphatic metastasis and LMO1 expression were identified to be independent risk factors affecting HCC survival; cells transfected with LMO1-siRNA showed significantly reduced proliferation, increased cell apoptosis and upregulated bax as well as downregulated bcl-2 (P < 0.05). In conclusion, LMO1 may affect the occurrence and development of HCC through regulation of the bcl-2/bax expression.

学科与关键词

关键词
Hepatocellular CacinomaLMO1baxbcl-2
相关
加载中…
  • Lamin B1 is a potential therapeutic target and prognostic biomarker for hepatocellular carcinoma
    Yang, Yongyu; Gao, Lei; Chen, Junzhang; Xiao, Wang; Liu, Ruoqi; Kan, Heping*Bioengineered, 2022, 13(4): 9211-9231.被引 5
  • Hematological and neurological expressed 1 (HN1) activates c-Myc signaling by inhibiting ubiquitin-mediated proteasomal degradation of c-Myc in hepatocellular carcinoma
    Feng, Jutao*; Liu, Yanmin; Fang, Tianling; Zhu, Jinrong; Wang, Guoying; Li, Jun*CELL BIOLOGY INTERNATIONAL, 2023, 47(3): 560-572.被引 3
  • Correlation between expression of p53, p21/WAF1, and MDM2 proteins and their prognostic significance in primary hepatocellular carcinoma
    Zhang M F; Zhang Z Y; Fu J; Yang Y F; Yun J P*Journal of Translational Medicine, 2009, 7.
查看全部 →

发表信息

论文状态
公开发表
期刊
Journal of Biomaterials and Tissue Engineering
发表日期
2023-03
卷期
第 13 卷, 第 3 期
页码
475-481
DOI
10.1166/jbt.2023.3277
语言
ENGLISH
成果收录
SCIE
资助标注
Guangdong Medical Research Foundation [A2018048]

作者

  • Z

    Zhang, Jianfeng (第一作者)

    southern med univ

  • P

    Peng, Bojian

    southern med univ

查看全部 9 位作者收起作者
  • L

    Li, Zhuowen

    southern med univ

  • Z

    Zhang, Yuan

  • Z

    Zhang, Yongjun

  • L

    Lu, Xiushan

    southern med univ

  • C

    Cao, Yanwen

    southern med univ

  • D

    Dai, Zijun

    southern med univ

  • X

    Xiong, Chuanyin (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417